Related Experiment Video
Updated: Aug 14, 2026

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
Published on: June 24, 2021
Identification of a novel splice variant of X-linked inhibitor of apoptosis-associated factor 1
Weihong Yin1, Satish Cheepala, John L Clifford
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Science Center School of Medicine in Shreveport and Feist-Weiller Cancer Center, 1501 Kings Highway, P.O. Box 33932, Shreveport, LA 71130, USA.
Abstract:
XAF1 (XIAP-associated factor 1) binds to XIAP and blocks its anti-apoptotic activity. It has been reported that XAF1 is mainly expressed in normal tissues but is missing or present at low levels in most cancer cell lines, which implies a tumor-suppressing function. In the present study we describe the identification of a novel splice variant of human XAF1, designated XAF1C, which contains a cryptic exon. Incorporation of this exon (exon 4b) into the mRNA introduces an in-frame stop codon, resulting in a shortened open-reading frame (ORF) of 495 nucleotides. This ORF is predicted to encode a 164 amino acid (AA) protein lacking the C-terminal domain of the previously described XAF1(A), but containing a unique 24 AA carboxy terminus. Like XAF1(A), XAF1C mRNA expression was detected in a variety of human cancer cell lines and also in normal human tissues. The ratio of XAF1(A) and XAF1C mRNA expression differs amongst the cell lines tested, suggesting differential mRNA stabilities and/or the existence of tissue- or cell type-specific splicing regulation. In transfected cells, xaf1c encodes a truncated protein of 18kDa, which is distributed primarily in the nucleus.
Insights
Researchers identified a new XAF1 variant, XAF1C, which may have a role in cancer. This truncated protein, XAF1C, is found in both normal and cancer cells, suggesting complex gene regulation.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- XIAP-associated factor 1 (XAF1) inhibits the anti-apoptotic protein XIAP.
- XAF1 is typically present in normal tissues but reduced in cancer cells, suggesting a tumor-suppressor role.
Purpose of the Study:
- To identify and characterize novel splice variants of human XAF1.
- To investigate the expression and potential function of the newly identified XAF1C variant.
Main Methods:
- Identification of a novel XAF1 splice variant (XAF1C) containing a cryptic exon.
- Analysis of mRNA expression of XAF1C in various human cancer cell lines and normal tissues.
- Expression and subcellular localization studies of the XAF1C protein in transfected cells.
Main Results:
- A novel XAF1 splice variant, XAF1C, was identified, resulting from the incorporation of a cryptic exon (exon 4b).
- XAF1C introduces an in-frame stop codon, leading to a truncated protein (164 amino acids) lacking the C-terminal domain of XAF1(A).
- XAF1C mRNA is expressed in both normal tissues and cancer cell lines, with varying ratios of XAF1(A) and XAF1C suggesting differential regulation.
Conclusions:
- The discovery of XAF1C reveals a new layer of complexity in XAF1 regulation.
- The differential expression of XAF1 variants may indicate tissue-specific splicing or varying mRNA stabilities.
- The truncated XAF1C protein localizes to the nucleus, hinting at distinct functional roles compared to the full-length XAF1(A).
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Inheritance of Chromatin Structures
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
The Intrinsic Apoptotic Pathway

